Lakeside Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Sell
15,376
-300
-2% -$64.5K 2.44% 13
2026
Q1
$3.41M Hold
15,676
2.28% 12
2025
Q4
$3.58M Hold
15,676
2.29% 12
2025
Q3
$3.63M Sell
15,676
-400
-2% -$81.5K 2.3% 11
2025
Q2
$2.98M Sell
16,076
-700
-4% -$130K 1.92% 13
2025
Q1
$3.51M Sell
16,776
-100
-0.6% -$19.4K 2.33% 12
2024
Q4
$3M Sell
16,876
-300
-2% -$55.2K 1.98% 13
2024
Q3
$3.39M Sell
17,176
-425
-2% -$79.3K 2.13% 12
2024
Q2
$3.02M Sell
17,601
-400
-2% -$66.3K 1.96% 12
2024
Q1
$3.28M Buy
18,001
+35
+0.2% +$6.03K 2.1% 12
2023
Q4
$2.78M Sell
17,966
-255
-1% -$37.2K 1.93% 13
2023
Q3
$2.72M Sell
18,221
-400
-2% -$58.7K 2.09% 12
2023
Q2
$2.51M Sell
18,621
-100
-0.5% -$14.7K 1.85% 13
2023
Q1
$2.98M Sell
18,721
-50
-0.3% -$7.64K 2.3% 13
2022
Q4
$3.03M Sell
18,771
-350
-2% -$53.7K 2.49% 13
2022
Q3
$2.57M Sell
19,121
-200
-1% -$28.7K 2.3% 13
2022
Q2
$2.96M Sell
19,321
-200
-1% -$30.6K 2.52% 12
2022
Q1
$3.17M Sell
19,521
-200
-1% -$29.1K 2.39% 11
2021
Q4
$2.67M Buy
+19,721
New +$2.33M 1.97% 13

Other funds holding ABBV

Lakeside Advisors's ABBV Position: Q2 2026 in Review

Lakeside Advisors reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $64.5K and leaving 15,376 shares worth $3.87M. The position accounts for 2.44% of the portfolio, ranked #13.

Lakeside Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,538 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lakeside Advisors held 15,376 shares of AbbVie worth $3.87M as of Q2 2026.
  • Lakeside Advisors sold 300 AbbVie shares in Q2 2026, an estimated $64.5K.
  • AbbVie made up 2.44% of Lakeside Advisors's portfolio in Q2 2026, its #13 holding.
  • Lakeside Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 2,538 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.